ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1α/PPAR-α signaling

Diabetes

Volumn 64, Issue 2, 2015, Pages 418-426

  Khan, Salmaan Ahmed ^a   Sathyanarayan, Aishwarya ^a   Mashek, Mara T ^a   Ong, Kuok Teong ^a   Wollaston Hayden, Edith E ^a   Mashek, Douglas G ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TRIGLYCERIDE LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 1; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; DESNUTRIN PROTEIN, MOUSE; PPARGC1A PROTEIN, MOUSE; SIRT1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ARTICLE; BIOGENESIS; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENE EXPRESSION; INTRACELLULAR SIGNALING; LIPOLYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; HEPATOCYTES; LIPASE; LIPOLYSIS; MALE; MICE; PPAR ALPHA; SIGNAL TRANSDUCTION; SIRTUIN 1; TRANSCRIPTION FACTORS;

EID: 84921921537     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0325     Document Type: Article

References (48)

1. Yoshizaki T, Schenk S, Imamura T, et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 2010;298:E419-E428
2. Wang R-H, Kim H-S, Xiao C, Xu X, Gavrilova O, Deng C-X. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. J Clin Invest 2011;121:4477-4490
3. Schug TT, Xu Q, Gao H, et al. Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol Cell Biol 2010;30:4712-4721
4. Banks AS, Kon N, Knight C, et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab 2008;8:333-341
5. Li Y, Xu S, Giles A, et al. Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J 2011;25:1664-1679
6. Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 1999;13:2570-2580
7. Cohen HY, Miller C, Bitterman KJ, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004;305:390-392
8. Rogina B, Helfand SL. Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci U S A 2004;101:15998-16003
9. Boily G, Seifert EL, Bevilacqua L, et al. SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One 2008;3:e1759.
10. Kim E-J, Kho J-H, Kang M-R, Um S-J. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 2007;28:277-290
11. Kim J-E, Chen J, Lou Z. DBC1 is a negative regulator of SIRT1. Nature 2008;451:583-586
12. Zhao W, Kruse J-P, Tang Y, Jung SY, Qin J, Gu W. Negative regulation of the deacetylase SIRT1 by DBC1. Nature 2008;451:587-590
13. Gerhart-Hines Z, Dominy JE Jr, Blättler SM, et al. The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD (+). Mol Cell 2011;44:851-863
14. Revollo JR, Li X. The ways and means that fine tune Sirt1 activity. Trends Biochem Sci 2013;38:160-167
15. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-α and SIRT1. Nature 2005;434:113-118
16. Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 2000;20:1868-1876
17. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999;103:1489-1498
18. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. Hepatocytespecific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 2009;9:327-338
19. Ong KT, Mashek MT, Bu SY, Greenberg AS, Mashek DG. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology 2011;53:116-126
20. Obrowsky S, Chandak PG, Patankar JV, et al. Adipose triglyceride lipase is a TG hydrolase of the small intestine and regulates intestinal PPARa signaling. J Lipid Res 2013;54:425-435
21. Haemmerle G, Moustafa T, Woelkart G, et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR- A and PGC-1. Nat Med 2011;17:1076-1085
22. Ahmadian M, Abbott MJ, Tang T, et al. Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab 2011;13:739-748
23. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors a and d. Proc Natl Acad Sci U S A 1997;94:4312-4317
24. Kliewer SA, Forman BM, Blumberg B, et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A 1994;91:7355-7359
25. Ong KT, Mashek MT, Davidson NO, Mashek DG. Hepatic ATGL mediates PPAR- A signaling and fatty acid channeling through an L-FABP independent mechanism. J Lipid Res 2014;55:808-815
26. Miyoshi H, Perfield JW 2nd, Souza SC, et al. Control of adipose triglyceride lipase action by serine 517 of perilipin A globally regulates protein kinase A-stimulated lipolysis in adipocytes. J Biol Chem 2007;282:996-1002
27. Miyoshi H, Perfield JW 2nd, Obin MS, Greenberg AS. Adipose triglyceride lipase regulates basal lipolysis and lipid droplet size in adipocytes. J Cell Biochem 2008;105:1430-1436
28. Bu SY, Mashek MT, Mashek DG. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity. J Biol Chem 2009;284:30474-30483
29. Yatsuga S, Suomalainen A. Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice. Hum Mol Genet 2012;21:526-535
30. Jaworski K, Sarkadi-Nagy E, Duncan RE, Ahmadian M, Sul HS. Regulation of triglyceride metabolism. IV. Hormonal regulation of lipolysis in adipose tissue. Am J Physiol Gastrointest Liver Physiol 2007;293:G1-G4
31. Nin V, Escande C, Chini CC, et al. Role of deleted in breast cancer 1 (DBC1) protein in SIRT1 deacetylase activation induced by protein kinase A and AMP-activated protein kinase. J Biol Chem 2012;287:23489-23501
32. Knutti D, Kressler D, Kralli A. Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc Natl Acad Sci U S A 2001;98:9713-9718
33. Palou M, Priego T, Sánchez J, et al. Sequential changes in the expression of genes involved in lipid metabolism in adipose tissue and liver in response to fasting. Pflugers Arch 2008;456:825-836
34. Adamovich Y, Shlomai A, Tsvetkov P, et al. The protein level of PGC-1a, a key metabolic regulator, is controlled by NADH-NQO1. Mol Cell Biol 2013;33:2603-2613
35. Sapiro JM, Mashek MT, Greenberg AS, Mashek DG. Hepatic triacylglycerol hydrolysis regulates peroxisome proliferator-activated receptor alpha activity. J Lipid Res 2009;50:1621-1629
36. Mottillo EP, Bloch AE, Leff T, Granneman JG. Lipolytic products activate peroxisome proliferator-activated receptor (PPAR) a and d in brown adipocytes to match fatty acid oxidation with supply. J Biol Chem 2012;287:25038-25048
37. Coleman RA, Mashek DG. Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling. Chem Rev 2011;111:6359-6386
38. Greenberg AS, Coleman RA, Kraemer FB, et al. The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest 2011;121:2102-2110
39. Mottillo EP, Granneman JG. Intracellular fatty acids suppress b-adrenergic induction of PKA-targeted gene expression in white adipocytes. Am J Physiol Endocrinol Metab 2011;301:E122-E131
40. Langin D. Adipose tissue lipolysis as a metabolic pathway to define pharmacological strategies against obesity and the metabolic syndrome. Pharmacol Res 2006;53:482-491
41. Ahmadian M, Duncan RE, Varady KA, et al. Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity. Diabetes 2009;58:855-866
42. Turpin SM, Hoy AJ, Brown RD, et al. Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice. Diabetologia 2011;54:146-156
43. Pulinilkunnil T, Kienesberger PC, Nagendran J, et al. Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy. Diabetes 2013;62:1464-1477
44. Sitnick MT, Basantani MK, Cai L, et al. Skeletal muscle triacylglycerol hydrolysis does not influence metabolic complications of obesity. Diabetes 2013;62:3350-3361
45. Baur JA, Ungvari Z, Minor RK, Le Couteur DG, De Cabo R. Are sirtuins viable targets for improving healthspan and lifespan? Nat Rev Drug Discov 2012;11:443-461
46. Grönke S, Mildner A, Fellert S, et al. Brummer lipase is an evolutionary conserved fat storage regulator in Drosophila. Cell Metab 2005;1:323-330
47. Wang MC, O'Rourke EJ, Ruvkun G. Fat metabolism links germline stem cells and longevity in C. Elegans. Science 2008;322:957-960
48. Lapierre LR, Gelino S, Meléndez A, Hansen M. Autophagy and lipid metabolism coordinately modulate life span in germline-less C. Elegans. Curr Biol 2011;21:1507-1514